Results 221 to 230 of about 104,018 (312)

CONJUNCTIVITIS IN THE TROPICS [PDF]

BMJ, 1925
openaire   +3 more sources

Conjunctivitis in Neonates [PDF]

Infection Control, 1984
Timothy W. Lane, Faye Dalton Ivey
openaire   +3 more sources

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial

Allergy, Volume 80, Issue 7, Page 1945-1955, July 2025.
Different functions of an allergy app were tested for clinical benefit in a randomized, controlled trial in patients with grass pollen allergy. Participants with pollen forecast function took more medication and had fewer symptoms than participants without pollen forecast. A symptom forecast was developed based on the study data.
Caroline Holzmann, Johannes Karg, Matthias Reiger, Rajiv Kharbal, Paola Romano, Sabrina Scheiwein, Claudia Khalfi, Anna Muzalyova, Jens O. Brunner, Gertrud Hammel, Athanasios Damialis, Claudia Traidl‐Hoffmann, María P. Plaza, Stefanie Gilles   +13 more
wiley   +1 more source

Pink eye outbreak in rural Borneo schools: The panic and the prompt public health response. [PDF]

J Family Community Med
Jiee SF, Aziz AS, Hee LS, Qamil MA, Ugak Y, Stephen J.   +5 more
europepmc   +1 more source

Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. [PDF]

, 1977
S Darougar, M P Quinlan, J A Gibson, B R Jones   +3 more
openalex   +1 more source

Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG1 Instead of IgG4

Allergy, Volume 80, Issue 7, Page 2018-2030, July 2025.
A 6‐month randomized, double‐blind, placebo‐controlled first‐in‐human clinical trial was conducted in birch pollen allergic patients comparing the Bet v 1‐fold‐variant BM41 with a licensed birch pollen extract‐based treatment, as active comparator, and placebo.
Lorenz Aglas, Line Kring Tannert, Serge A. Versteeg, Scott A. Smith, Ewa A. Bartko, Mario Wenger, Amin Kraiem, Hannah Widauer, Natália Nunes, Sibile Sinkunaite, Frank Stolz, Laurian Jongejan, Angela Neubauer, Lars H. Blom, Fatima Ferreira, Lars K. Poulsen, Carsten Bindslev‐Jensen, Ronald van Ree   +17 more
wiley   +1 more source

2024 re-emergence of coxsackievirus A24 variant causing an outbreak of acute hemorrhagic conjunctivitis in the South West Indian Ocean. [PDF]

Emerg Microbes Infect
Mirand A, Bisseux M, Collet L, Lacoste V, Pierres V, Raharinantoanina J, Razafindratsimandresy R, Chabrolles H, Bailly JL, Bessaud M, Lapostolle A, Henquell C.   +11 more
europepmc   +1 more source

Severe endemic trachoma in Tunisia. I. Effect of topical chemotherapy on conjunctivitis and ocular bacteria. [PDF]

, 1974
David W. Vastine, Chandler R. Dawson, T. Daghfous, M Messadi, I. Hoshiwara, Chieko Yoneda, R. Nataf   +6 more
openalex   +1 more source

Maternal–fetal transfer and longitudinal trends of antibodies to Chlamydia trachomatis and Mycoplasma genitalium in early childhood

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 7, Page 1366-1372, July 2025.
Maternal IgG antibodies against Chlamydia trachomatis and Mycoplasma genitalium are transferred to the fetus during pregnancy, like other IgG antibodies. Early‐life seroconversion to these pathogens was uncommon. Abstract Introduction Sexually transmitted infections caused by Chlamydia trachomatis and Mycoplasma genitalium can have significant ...
Nea Koskela, Julia Butt, Birgitta E. Michels, Kari Syrjänen, Seija Grenman, Tim Waterboer, Stina Syrjänen, Karolina Louvanto   +7 more
wiley   +1 more source

Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab? [PDF]

Dermatol Ther (Heidelb)
Sebastian N, Chircop O, Clayton TH, Kreeshan FC, Hunter HJA, Warren RB.   +5 more
europepmc   +1 more source